CRMD Q1 2023 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena

CRMDCorMedix Inc.

$536M

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$49,445

Operating Income

-$11M

Net Income

-$11M

EPS (Diluted)

$9.77

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$59M

Total Liabilities

$5M

Stockholders' Equity

$54M

Cash & Equivalents

$25M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$7,636	-100.0%
Gross Profit	-$49,445	$6,109	-909.4%
Operating Income	-$11M	-$7M	-56.7%
Net Income	-$11M	-$7M	-50.2%